Tudor Investment Corp’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,157
| Closed | -$20.8K | – | 2287 |
|
|
2024
Q4 | $20.8K | Hold |
2,157
| – | – | ﹤0.01% | 1466 |
|
|
2024
Q3 | $40.1K | Hold |
2,157
| – | – | ﹤0.01% | 1482 |
|
|
2024
Q2 | $35.9K | Hold |
2,157
| – | – | ﹤0.01% | 1438 |
|
|
2024
Q1 | $37.5K | Hold |
2,157
| – | – | ﹤0.01% | 1392 |
|
|
2023
Q4 | $33.7K | Hold |
2,157
| – | – | ﹤0.01% | 1401 |
|
|
2023
Q3 | $107K | Sell |
2,157
-1,044
| -33% | -$51.6K | ﹤0.01% | 1381 |
|
|
2023
Q2 | $250K | Buy |
3,201
+2,037
| +175% | +$159K | ﹤0.01% | 1314 |
|
|
2023
Q1 | $105K | Buy |
+1,164
| New | +$105K | ﹤0.01% | 1446 |
|
|
2022
Q4 | – | Sell |
-1,115
| Closed | -$202K | – | 2051 |
|
|
2022
Q3 | $202K | Sell |
1,115
-502
| -31% | -$90.9K | ﹤0.01% | 1415 |
|
|
2022
Q2 | $145K | Buy |
1,617
+569
| +54% | +$51K | ﹤0.01% | 1417 |
|
|
2022
Q1 | $163K | Sell |
1,048
-25
| -2% | -$3.89K | ﹤0.01% | 1403 |
|
|
2021
Q4 | $319K | Buy |
+1,073
| New | +$319K | 0.01% | 1311 |
|
|
2021
Q3 | – | Sell |
-1,543
| Closed | -$700K | – | 2053 |
|
|
2021
Q2 | $700K | Buy |
+1,543
| New | +$700K | 0.01% | 967 |
|